Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy

Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy

Bibliographic Details
Main Authors:	Ariany Oliveira-Santos, Marisela Dagda, Jennifer Wittmann, Robert Smalley, Dean J. Burkin
Format:	Article
Language:	English
Published:	The Company of Biologists 2023-06-01
Series:	Disease Models & Mechanisms
Subjects:	lama2-cmd congenital muscular dystrophy mdc1a laminin-α2 tgf-β mtor vemurafenib
Online Access:	http://dmm.biologists.org/content/16/6/dmm049916

Similar Items

Limb girdle muscular dystrophy 23 caused by compound heterozygous mutations of LAMA2 gene
by: Yuqing Xu, et al.
Published: (2023-06-01)

Congenital muscular dystrophy with inflammation: Diagnostic considerations
by: Kaumudi Konkay, et al.
Published: (2016-01-01)

Merosin-deficient congenital muscular dystrophy type 1a: detection of LAMA2 variants in Vietnamese patients
by: Van Khanh Tran, et al.
Published: (2023-06-01)

Novel compound heterozygous mutations of LAMA2-limb–girdle muscular dystrophy: A case report and literature review
by: Duo-Zi Wang, et al.
Published: (2023-02-01)

Case report: Novel frameshift mutation in LAMA2 gene causing congenital muscular dystrophy type 1A
by: Natalia Diaz-Lombana, et al.
Published: (2023-06-01)

Case report: Adult-onset limb girdle muscular dystrophy in sibling pair due to novel homozygous LAMA2 missense variant
by: Matthew Katz, et al.
Published: (2023-01-01)

Novel mutation identification and copy number variant detection via exome sequencing in congenital muscular dystrophy
by: Edmund S. Cauley, et al.
Published: (2020-11-01)

Antioxidants Reduce Muscular Dystrophy in the <i>dy<sup>2J</sup>/dy<sup>2J</sup></i> Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
by: Vahid M. Harandi, et al.
Published: (2020-03-01)

Causative variants linked with limb girdle muscular dystrophy in an Iranian population: 6 novel variants
by: Hamidreza Mianesaz, et al.
Published: (2023-02-01)

Whole Exome Sequencing as a Diagnostic Tool for Unidentified Muscular Dystrophy in a Vietnamese Family
by: Ngoc-Lan Nguyen, et al.
Published: (2020-09-01)

Early versus late diagnosis of LAMA2 congenital muscular dystrophy: a distinct consequence
by: Chien-Heng Lin, et al.
Published: (2024-01-01)

RNA analysis of intronic variants in the LAMA2 gene detected by whole genome sequencing confirms a rare dual diagnosis of incontinentia pigmenti with limb‐girdle muscular dystrophy
by: Camerun Washington, et al.
Published: (2023-04-01)

Unique genotype-phenotype correlations within LAMA2-related limb girdle muscular dystrophy in Chinese patients
by: Xiuli Huang, et al.
Published: (2023-05-01)

Muscular Dystrophy /
by: Naff, Clay Farris, editor 192865, et al.
Published: (2012)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Limb-girdle muscular dystrophy type 2B (LGMD2B) caused by pathogenic splice and missense variants of DYSF gene among Iranians with muscular dystrophy
by: Fatemeh Arab, et al.
Published: (2023-01-01)

Molecular targets to treat muscular dystrophies
by: Jochen Kinter, et al.
Published: (2014-02-01)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
by: Martina Sandonà, et al.
Published: (2023-02-01)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

Orofacial Manifestations Associated with Muscular Dystrophies: A Review
by: Petros Papaefthymiou, et al.
Published: (2022-03-01)

Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01)

POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan
by: Ameya S Walimbe, et al.
Published: (2020-09-01)

P2 Receptor Signaling in Motor Units in Muscular Dystrophy
by: Adel E. Khairullin, et al.
Published: (2023-01-01)

Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
by: van Westering, T
Published: (2018)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
by: Michael Ogundele, et al.
Published: (2021-08-01)

The golden retriever model of Duchenne muscular dystrophy
by: Joe N. Kornegay
Published: (2017-05-01)

The X‐linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45–47
by: Christopher R. Heier, et al.
Published: (2023-04-01)

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01)

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
by: Pietro Spitali, et al.
Published: (2018-08-01)

Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States
by: Erika J. Mejia, et al.
Published: (2022-04-01)

Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies
by: José Luis García-Giménez, et al.
Published: (2022-12-01)

Molecular Characterization of Dystrophin Gene in Iraqi Patients with Muscular Dystrophy.
by: Areen T. Ramadhan Al-Hadithi, et al.
Published: (2014-07-01)

Timed immersion expiration measures in patients with muscular dystrophies
by: Mariana Callil Voos, et al.
Published: (2020-02-01)

The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies
by: Woo Hyun Yoo, et al.
Published: (2017-06-01)

Advances in diagnosis and treatment of limb-girdle muscular dystrophy
by: Meng YU, et al.
Published: (2017-08-01)

P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular Dystrophy
by: Lizzia Raffaghello, et al.
Published: (2022-01-01)

The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies
by: Krzysztof Zabłocki, et al.
Published: (2023-05-01)

The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study
by: Aydan Kansu, et al.
Published: (2023-09-01)

Genetic Modifiers and Phenotype of Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis
by: Carlos Pascual-Morena, et al.
Published: (2021-08-01)